Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134706
Status:
COMPLETED
Last Update Posted:
2009-12-09
First Post:
2005-08-24
Brief Title:
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
03-319
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Mary-Ellen Taplin MD
Old Organization:
Dana-Farber Cancer Institute
Collaborators
| Name | Class |
|---|---|
| Wentworth-Douglass Hospital | OTHER |
| Bristol-Myers Squibb | INDUSTRY |
| Beth Israel Deaconess Medical Center | OTHER |
| Lowell General Hospital | OTHER |
| Massachusetts General Hospital | OTHER |
| Oregon Health and Science University | OTHER |